Introduction
Diabetes is a chronic progressive disease and one of leading causes of death in developed and developing countries [1] . In the past three decades, the occurrences of type 2 diabetic have augmented dramatically in developing countries. Over time, diabetes causes various complications: It starts by damaging blood vessels, reducing the blood flow, with sequelae that may be macrovascular (heart attack, stroke, and heart failure) [2] . About 422 million people have suffered from diabetes worldwide and the number will increase by 418 million in near future [3] . Clinical and epidemiological investigations have confirmed that chronic hyperglycemia and oxidative damages are the major causative factors of diabetes by activating polyol pathway, stimulating glucose auto-oxidation and glycating proteins [4] .
Objective: To assess the protective effect of galangin on membrane bound enzymes in rats with streptozotocin-induced diabetes.
The membrane-bound adenosine triphosphatases play an important role in ion transport across cell membrane, which helps to regulate osmotic pressure, cellular volume and membrane diffusion [4] . Sustained hyperglycemia has generated major causative factor of superoxide anion by glucose autooxidation in chemically induced diabetic rats and diabetic patients [5] . Oxidative injury (superoxide radicals) causes membrane phospholipid peroxidation, resulting in membrane damage and cellular dysfunction. Membrane peroxidation also alters membrane-bound adenosine triphosphatases such as sodium-potassium-ATPase, calcium-ATPase, and magnesium ATPase [6, 7] .
Food beverage or plants act as major therapeutic agents in modern and traditional medicines. A wide variety of traditional plants products have been used as antidiabetic agents by researchers because they have few side effects and can act as a great auxiliary therapeutic drug [8] . Natural phenolic compound of flavonoids is widely found in plants. Flavonoids have several clinical properties including antidiabetic [9, 10] , antihypertensive [11] , anticancer [12] and anti-hepatotoxicity [13] . Galangin is one such bioflavonoid found in Alpinia officinarum. Several medicinal benefits of galangin have been confirmed by researchers that include the hyperglycemic lowering activity [14] , preventive or inhibitory role of cells inflammation [15] , reduction of the tissues or cells damages by anti-oxidant effective role [16] , and inhibition on different types of cancer growth by anti-apoptotic and proliferative effects. Our previous study also confirmed that the galangin had antihyperglycemic and antioxidant properties [14] . It is also reported that galangin could stimulate the ATPase enzyme activities [17] and inhibit H + /K + /ATPase [18] .
Streptozotocin causes insulin deficiency and hyperglycemia by destruction of pancreatic 毬 -cell in animals, and is widely used to establish diabetic animal model [19] . So we selected streptozotocin for modeling in our study. To the best of our knowledge, no studies have been done on the effect of galangin on membrane-bound enzymes. Therefore, our aim was to study the protective effect of galangin on membrane bound enzymes in rats with streptozotocin induced hyperglycemia.
Materials and methods

Animals
Albino Wistar rats (Male only), weighing 180 to 220 g, were brought from Central Animal House, King Saud University.
These animals were accommodated in polypropylene cage in air- 
Chemicals and treated drugs purchasing
Hyperglycemia induction in animals
Animals (overnight fasted) were injected (intraperitoneally) with low and single dosage of streptozotocin (40 mg) prepared with 0.1 M citrate buffer (pH 4.5) to induce hyperglycemia [15] . To prevent mortality due to streptozotocin, 20% of glucose was administered for one day. Ninety-six hours after streptozotocin-induction, diabetes was confirmed by estimating the glucose level. Animals with plasma glucose above 180 mg/dL were selected for further experiments.
Grouping
A total of 42 rats were randomly allocated into seven groups 6 rats per group. In our earlier study where the acute oral toxicity study of galangin was reported and it had no signs of toxicity even at the highest dose of 320 mg/kg [14] . Hence, in this study, galangin at 4, 8 and 16 mg/kg was selected and this drug or glibenclamide at 600 µg/ kg mixed with dimethyl sulfoxide (5%) was given orally once daily for 45 d. 
Grouping for further study
Thirty rats were randomly separated into five groups (each group having 6 rats). Galangin at 8 mg/kg or 600 µg/kg glibenclamide (mixed with dimethyl sulfoxide 5%) was treated daily once for 45 d. The 8 mg/kg of galangin showed optimized activity of glucose lowering than other two doses such as 4 and 16 mg/kg [14] . Hence, this active dose of 8 mg/kg was used for further experiments. After 45 days of treatment, rats were fasted for 12 h, then sacrificed by cervical dislocation. Blood collected and erythrocytes were isolated as the following procedure. The buffy coat was collected after the plasma isolation and then the white cells were detached.
The remaining section of erythrocytes was thoroughly cleaned with physiological saline. Afterwards, erythrocyte was lysed with hypotonic phosphate buffer at pH 7.4. The hemolysate was isolated by 2 500 rpm centrifugation for 10 min and the supernatant was used for the measurement of membrane bound ATPases. Moreover, liver, kidney and heart were collected for the measurement of membrane bound ATPases.
Biochemical assays
Plasma glucose was measured by the Trinder reagent kit method [20] .
Total protein from tissues was measured by Lowry et al [21] method.
Erythrocytes, liver, kidney and heart total ATPase activity was measured using Evans method [22] , and sodium-potassium-ATPase activity based on Bonting method [23] . Moreover, calcium-ATPase and magnesium-ATPase activities were determined by Hjerten and
Pan [24] and Ohnishi et al [25] , respectively.
Statistical analysis
Results were calculated by one-way analysis (ANOVA) of Duncan's multiple range test (DMRT) with the commercially available statistical analysis SPSS software (9.05). Results were expressed as mean ± SD. P values < 0.05 were considered significant.
Results
Effect of galangin on glucose and body weight
Body weight was decreased and plasma glucose increased in rats with streptozotocin-induced hyperglycemia. Meanwhile, galangin or glibenclamide improved these alterations to almost normal level.
Rats treated with 8 mg/kg of galangin showed the better result of glucose and body weight than the other two doses (Figure 1 ).
Effect galangin on ATPase activities
Figures 2-5 show that activities of total ATPase, sodiumpotassium-ATPase, calcium-ATPase and magnesium-ATPase in tissues (liver, kidney, and heart) and erythrocytes all decreased in rats with streptozotocin-induced hyperglycemia. But galangin or glibenclamide significantly increased the activity of these enzymes.
Discussion
Chronic hyperglycemia accompanied by insulin resistance with or without insulin deficiency (type-2 diabetics) is associated with many diabetic complications as an outcome of oxidative damage to organs.
Increased oxidative stress and reduced antioxidants occur during diabetes by glucose autoxidation and protein glycosylation [26, 27] .
Sodium-potassium-ATPase, calcium-ATPase, and magnesium- ATPase play a major role in the maintenance of ion transport, electrolyte balance and cell volume regulations [28, 29] . The membranebound adenosine triphosphatases activities (i.e. Na Sodium-potassium-ATPase moves two potassium ions into cell and carries three sodium ions out of the cell, which played an important role in cellular homeostasis [31] . Insulin plays an active role in biosynthesis of sodium-potassium-ATPase [32] . A recent study has reported that the sodium potassium-ATPase activity decreases significantly in liver, heart and erythrocytes of chemically- induced hyperglycemia in rats [33] . The cellular membrane damage caused by free radicals results in reduction of sodium-potassiumATPase activity. Reduced activity of sodium-potassium-ATPase may contribute to the pathophysiology of diabetic complicated risks [34] . Oxidation of thiol groups is abundant in sodium-potassiumATPase, which could be involved in control of sodium-potassiumATPase activity. Lipid and protein changes in the cellular membrane caused sodium-potassium-ATPase activity in chronic hyperglycemic patients [35] . In this current study, decreased activity of sodiumpotassium-ATPase was observed in chemically streptozotocininduced hyperglycemia in rats. Treatment with galangin and glibenclamide brought sodium-potassium-ATPase activity towards normalcy, by insulin secretion effect and/or by preventing damage to membrane lipids by oxidative stress. Moreover, Gupta et al [36] have discovered that insulin treatment with chronic hyperglycemic state partially restored sodium-potassium-ATPase activity.
Calcium and magnesium ATPases are found in cellular membranes, which are dependable for preserving calcium gradient [37] . and Mg 2+ -ATPases in uncontrolled high blood glucose status [40] .
Oral therapy of galangin and glibenclamide had restored the Ca
2+
and Mg
-ATPases activities towards normal levels. Thus improved ATPase activity could be due to it increased secretion or activity of insulin, reduced membrane phospholipids damages and improved glycaemic control.
Galangin treatment enhanced the functions of total ATPase, sodium-potassium-ATPase, calcium-ATPase and magnesium-ATPase in diabetic rats, which could be attributed to enhanced insulin secretion, antioxidant status and the glucose lowering activity. In our previous reports, we claimed that galangin significantly lowered the glucose and increased the insulin secretion in diabetic rats [14] .
Antioxidant is a therapeutic agent for many disorders complication including diabetes, hypertension and cancer. It's also associated with the protective effect on abnormal ATPase activities through the diminished oxidative stress in streptozotocin induced diabetic rats. Galangin with the antioxidant potential possibly decreases the membrane lipid peroxides. Our previous study showed the galangin acts as a potent antioxidant in diabetic rats [14] . The active metabolites of galangin such as kaempferol and quercetin are identified by in vitro studies, which could be responsible for the several biological effects including anti-diabetic, anti-oxidant and membrane bound enzyme activities [41] .
In conclusion, galangin ameliorates membrane-bound ATPase changes in tissues (liver, kidney, and heart) and erythrocytes in diabetic rats. Mechanism of galangin could be further evaluated in future.
